Studying the potential of upregulated PTGS2 and VEGF-C besides

Por um escritor misterioso

Last updated 18 outubro 2024

Studying the potential of upregulated PTGS2 and VEGF-C besides

Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders, Stem Cell Research & Therapy

Cell Proliferation, Cell Biology Journal

Cells, Free Full-Text

In vivo transcriptomic profile after a Mediterranean diet in high–cardiovascular risk patients: a randomized controlled trial123 - The American Journal of Clinical Nutrition

Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma. - Abstract - Europe PMC

Neuroinflammation Plays a Critical Role in Cerebral Cavernous Malformation Disease

Anti-mesothelin immunotoxin induces mesothelioma eradication, anti-tumor immunity, and the development of tertiary lymphoid structures

JCI - Cyclooxygenase-2 in adipose tissue macrophages limits adipose tissue dysfunction in obese mice

Inflammatory and Innate Immune Cells in Cancer Microenvironment and Progression

Programmed cell death in aortic aneurysm and dissection: A potential therapeutic target - Journal of Molecular and Cellular Cardiology

Identification of GINS2 prognostic potential and involvement in immune cell infiltration in hepatocellular carcinoma

Preeclampsia—Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review

Bioinformatics and System Biological Approaches for the Identification of Genetic Risk Factors in the Progression of Cardiovascular Disease

VEGF-C and mutant VEGF-C promote leukemic cell proliferation. (A) THP-1

Recomendado para você